Dapagliflozin 10 mg + Metformin Hydrochloride 500 mg (SR) Tablets A powerful dual therapy for the effective management of Type 2 Diabetes Mellitus. Dapagliflozin, an SGLT2 inhibitor, helps lower blood glucose by promoting urinary glucose excretion, while Metformin (SR) improves insulin sensitivity and controls hepatic glucose production. This sustained-release formulation ensures prolonged glycemic control with enhanced patient compliance and fewer gastrointestinal side effects.